Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://www.prnewswire.com/news-releases/claritys-theranostic-prostate-cancer-trial-advances-to-multi-dose-phase-302090137.html
Mar 15, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next